Menu
Back to User profile » Dr Takashi Kanbayashi
Papers published by Dr Takashi Kanbayashi:
Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study
Takeshima M, Ishikawa H, Kanbayashi T, Shimizu T
Neuropsychiatric Disease and Treatment 2018, 14:3179-3184
Published Date: 22 November 2018
Inpatient phase-advance therapy for delayed sleep–wake phase disorder: a retrospective study
Takeshima M, Shimizu T, Echizenya M, Ishikawa H, Kanbayashi T
Nature and Science of Sleep 2018, 10:327-333
Published Date: 12 October 2018
Incidence of venous thromboembolism in psychiatric inpatients: a chart review
Takeshima M, Ishikawa H, Shimizu K, Kanbayashi T, Shimizu T
Neuropsychiatric Disease and Treatment 2018, 14:1363-1370
Published Date: 23 May 2018
Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T
Neuropsychiatric Disease and Treatment 2018, 14:1307-1308
Published Date: 22 May 2018
Low dose of aripiprazole advanced sleep rhythm and reduced nocturnal sleep time in the patients with delayed sleep phase syndrome: an open-labeled clinical observation
Omori Y, Kanbayashi T, Sagawa Y, Imanishi A, Tsutsui K, Takahashi Y, Takeshima M, Takaki M, Nishino S, Shimizu T
Neuropsychiatric Disease and Treatment 2018, 14:1281-1286
Published Date: 18 May 2018
Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness
Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T
Neuropsychiatric Disease and Treatment 2018, 14:451-457
Published Date: 8 February 2018
N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients: case reports and methods for detection
Tsutsui K, Kanbayashi T, Takaki M, Omori Y, Imai Y, Nishino S, Tanaka K, Shimizu T
Neuropsychiatric Disease and Treatment 2017, 13:339-345
Published Date: 8 February 2017